Hong Kong-based medical devices maker OrbusNeich rakes in $200m

Visuals from OrbusNeich's website

OrbusNeich Medical Group Limited, a Hong Kong-based firm that develops medical devices for vascular intervention, has secured $200 million in two funding rounds to double down on its new and existing product development in Greater China and worldwide.

The transactions were led by China’s Shenzhen Capital Group, together with its healthcare-focused investment platform Red Earth Healthcare Investment Fund, the investee announced on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter